Relay Therapeutics, Inc. Fair Value Adjustment of Warrants
Relay Therapeutics, Inc. (RLAY) reported Fair Value Adjustment of Warrants of -$4.59 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2022-05-05
- Relay Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2022-03-31 was -$4.59M.
- Relay Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2021-12-31 was $836.00K.
- Relay Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2021-09-30 was $2.00M.
- Relay Therapeutics, Inc. fair value adjustment of warrants for fiscal 2021 was $2.84M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$4.59M 10-Q · filed 2022-05-05 | -$3.76M derived: sum of 2 quarters · filed 2022-05-05 | -$1.76M derived: sum of 3 quarters · filed 2022-05-05 | |
| 2021-12-31 | $836.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $2.84M derived: sum of 2 quarters · filed 2022-02-24 | $2.84M 10-K · filed 2022-02-24 | |
| 2021-09-30 | $2.00M 10-Q · filed 2021-11-10 | $2.00M 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |